.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Covington
Medtronic
Harvard Business School
QuintilesIMS
Cerilliant
Fuji
Chinese Patent Office
Argus Health
Johnson and Johnson

Generated: July 25, 2017

DrugPatentWatch Database Preview

Danazol - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for danazol and what is the scope of danazol freedom to operate?

Danazol
is the generic ingredient in two branded drugs marketed by Lannett, Sanofi Aventis Us, Am Therap, and Barr, and is included in four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for danazol. Four suppliers are listed for this compound.

Summary for Generic Name: danazol

Tradenames:2
Patents:1
Applicants:4
NDAs:4
Drug Master File Entries: see list8
Suppliers / Packagers: see list4
Bulk Api Vendors: see list27
Clinical Trials: see list18
Patent Applications: see list4,630
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:danazol at DailyMed

Pharmacology for Ingredient: danazol

Ingredient-typeAndrostanes
Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett
DANAZOL
danazol
CAPSULE;ORAL077246-003Apr 19, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Barr
DANAZOL
danazol
CAPSULE;ORAL074582-002May 29, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis Us
DANOCRINE
danazol
CAPSULE;ORAL017557-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lannett
DANAZOL
danazol
CAPSULE;ORAL077246-002Apr 19, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Barr
DANAZOL
danazol
CAPSULE;ORAL074582-003May 29, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Cerilliant
Novartis
Teva
Fish and Richardson
Moodys
McKinsey
US Department of Justice
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot